In both 2025 and the first quarter of 2026, the Company derived 100 % of its contract manufacturing revenue from a single customer, resulting in a significant concentration of revenue risk.
On February 21, 2024, the Company entered into a five-year Supply Agreement with a third-party biotechnology company developing multiple, novel secretomes
Longeveron Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
LGVN-DEBT-10697
Warrants outstanding: 0.001
90%
xbrl warrant detail from xbrl 2023-12-31.
LGVN-DEBT
Debt stack $748,000
90%
Market cache reports total debt of $748,000.
Longeveron Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Longeveron Inc..
Longeveron Inc. Ownership
Holder
Name
Confidence
Evidence
LGVN-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 31 tracked holders.
Longeveron Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.